Annual Shareholders Equity
$87.80 M
-$44.48 M-33.62%
December 31, 2023
Summary
- As of February 7, 2025, OVID annual stockholders equity is $87.80 million, with the most recent change of -$44.48 million (-33.62%) on December 31, 2023.
- During the last 3 years, OVID annual shareholders equity has risen by +$44.17 million (+101.22%).
- OVID annual shareholders equity is now -51.16% below its all-time high of $179.75 million, reached on December 31, 2021.
Performance
OVID Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$76.29 M
-$12.61 M-14.19%
September 30, 2024
Summary
- As of February 7, 2025, OVID quarterly stockholders equity is $76.29 million, with the most recent change of -$12.61 million (-14.19%) on September 30, 2024.
- Over the past year, OVID quarterly shareholders equity has dropped by -$11.51 million (-13.11%).
- OVID quarterly shareholders equity is now -65.50% below its all-time high of $221.11 million, reached on March 31, 2021.
Performance
OVID Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
OVID Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.6% | -13.1% |
| 3 y3 years | +101.2% | -13.1% |
| 5 y5 years | +126.3% | -13.1% |
OVID Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.2% | at low | -57.6% | at low |
| 5 y | 5-year | -51.2% | +101.2% | -65.5% | +150.3% |
| alltime | all time | -51.2% | +126.3% | -65.5% | +153.9% |
Ovid Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $76.29 M(-14.2%) |
| Jun 2024 | - | $88.90 M(+13.6%) |
| Mar 2024 | - | $78.28 M(-10.8%) |
| Dec 2023 | $87.80 M(-33.6%) | $87.80 M(-13.3%) |
| Sep 2023 | - | $101.29 M(-8.5%) |
| Jun 2023 | - | $110.70 M(-8.5%) |
| Mar 2023 | - | $120.95 M(-8.6%) |
| Dec 2022 | $132.27 M(-26.4%) | $132.27 M(-6.9%) |
| Sep 2022 | - | $142.05 M(-6.6%) |
| Jun 2022 | - | $152.15 M(-7.8%) |
| Mar 2022 | - | $165.00 M(-8.2%) |
| Dec 2021 | $179.75 M(+312.0%) | $179.75 M(-8.8%) |
| Sep 2021 | - | $197.02 M(-4.7%) |
| Jun 2021 | - | $206.71 M(-6.5%) |
| Mar 2021 | - | $221.11 M(+406.8%) |
| Dec 2020 | $43.63 M | $43.63 M(-31.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $63.64 M(+108.8%) |
| Jun 2020 | - | $30.48 M(-40.7%) |
| Mar 2020 | - | $51.44 M(-26.5%) |
| Dec 2019 | $70.02 M(+80.4%) | $70.02 M(+133.0%) |
| Sep 2019 | - | $30.05 M(-33.9%) |
| Jun 2019 | - | $45.44 M(-20.6%) |
| Mar 2019 | - | $57.25 M(+47.5%) |
| Dec 2018 | $38.81 M(-53.5%) | $38.81 M(-22.3%) |
| Sep 2018 | - | $49.97 M(-18.2%) |
| Jun 2018 | - | $61.12 M(-15.2%) |
| Mar 2018 | - | $72.09 M(-13.6%) |
| Dec 2017 | $83.44 M(+69.3%) | $83.44 M(-10.2%) |
| Sep 2017 | - | $92.96 M(-7.9%) |
| Jun 2017 | - | $100.94 M(+138.4%) |
| Mar 2017 | - | $42.34 M(-14.1%) |
| Dec 2016 | $49.29 M(-27.6%) | $49.29 M |
| Dec 2015 | $68.07 M | - |
FAQ
- What is Ovid Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Ovid Therapeutics?
- What is Ovid Therapeutics annual shareholders equity year-on-year change?
- What is Ovid Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly shareholders equity year-on-year change?
What is Ovid Therapeutics annual stockholders equity?
The current annual shareholders equity of OVID is $87.80 M
What is the all time high annual shareholders equity for Ovid Therapeutics?
Ovid Therapeutics all-time high annual stockholders equity is $179.75 M
What is Ovid Therapeutics annual shareholders equity year-on-year change?
Over the past year, OVID annual stockholders equity has changed by -$44.48 M (-33.62%)
What is Ovid Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of OVID is $76.29 M
What is the all time high quarterly shareholders equity for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly stockholders equity is $221.11 M
What is Ovid Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, OVID quarterly stockholders equity has changed by -$11.51 M (-13.11%)